<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00908193</url>
  </required_header>
  <id_info>
    <org_study_id>P051080</org_study_id>
    <nct_id>NCT00908193</nct_id>
  </id_info>
  <brief_title>Laparoscopic &quot;DA VINCI&quot; Robot Assisted Abdominal Wall Hernia Repair</brief_title>
  <acronym>ARTE</acronym>
  <official_title>Assistance Robotics for the Surgical Treatment of the Abdominal Wall Hernia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to prove the superiority of the robotic assistance in laparoscopic
      repair of abdominal wall hernias .

      In this monocentric randomized controlled trial, the use of the DA VINCI robot might reduce
      the post-operative pain of the patient resulting in a 40% reduction of morphine consumption.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic Robot Assisted abdominal wall hernia repair : a prospective randomized trial:

      The main judgement criterion is post operative pain reflected by morphine consumption during
      the first 48 hours. Secondary criteria are morbidity, quality of life, duration of surgery,
      conversion rate, complications, the the length of stay and hospital costs.

      In this single centre study, inclusion criteria are age above 18, no previous repair of the
      hernia with a mesh and a diameter of the parietal defect of less than 10 cm.
      Contraindications are chronic use of pain drugs of level II or above and renal insufficiency
      (clearance &lt;30ml/min).

      The robotic repair was described in a previous paper of our group and will be compared to our
      classical laparoscopic repair technique, and in both cases with the use of the same
      prosthetic mesh.

      A total of 70 patients to be included in an 18 months period was calculated to prove a 40%
      reduction in morphine consumption during the postoperative 48h (α=5% and β=10%).

      The total duration of the study is 30 months (12 months of follow-up for each patient).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the reduction in morphine consumption</measure>
    <time_frame>during the postoperative 48h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain patient (ENS, total consumption of morphine)</measure>
    <time_frame>during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life (questionary SF-36)</measure>
    <time_frame>1 month, 6 month and 12 month of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in hospital, percentage return home to 24 hours of surgery</measure>
    <time_frame>to 24 hours of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morbidity</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resumption of work</measure>
    <time_frame>after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Abdominal Wall Hernia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>robot-assisted coelioscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional coelioscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic DA VINCI Robot Assisted coelioscopy</intervention_name>
    <description>Patients with abdominal wall hernia will be treated by robot-assisted coelioscopy for the poses of abdominal plate</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Laparoscopic DA VINCI Robot Assisted abdominal coelioscopy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional coelioscopy</intervention_name>
    <description>Patients with abdominal wall hernia will be treated by conventional coelioscopy for the poses of abdominal plate</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 18 years

          -  with indication of hernia repair

          -  a collar with a diameter of less than 10cm

          -  no antecedent of hernia treatment with poses plate

          -  agreeing coelioscopy

          -  agreeing to participate the clinical study, having sign an informed consent

          -  agreeing a regular monitor

        Exclusion Criteria:

          -  taking analgesic tier 2 or 3

          -  against indication to anesthetics or coelioscopy

          -  creatinine clearance less than 30 ml/min

          -  pregnant woman and protected persons

          -  no affiliation to social security

          -  unable to understand the information form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claude Tayar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Chenevier-Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2009</study_first_submitted>
  <study_first_submitted_qc>May 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2009</study_first_posted>
  <last_update_submitted>August 1, 2013</last_update_submitted>
  <last_update_submitted_qc>August 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Treatment of abdominal ruptured</keyword>
  <keyword>Digestive system disease</keyword>
  <keyword>Coelioscopy</keyword>
  <keyword>Assistance robotics</keyword>
  <keyword>Medical device</keyword>
  <keyword>DA VINCI Robot</keyword>
  <keyword>Pain patient</keyword>
  <keyword>Morphine consumption</keyword>
  <keyword>Comparative Randomized study</keyword>
  <keyword>patient over 18 years</keyword>
  <keyword>with ruptured abdominal</keyword>
  <keyword>with an indication of treatment of ruptured</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

